Status:
RECRUITING
Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women With Preeclampsia
Lead Sponsor:
Istanbul University - Cerrahpasa
Conditions:
Pre-Eclampsia
Maternal Health
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Preeclampsia, affecting 2-8% of pregnancies globally, is a leading hypertensive disorder in pregnancy. It is clinically characterized by elevated blood pressure (≥140/90 mmHg) after the 20th gestation...
Eligibility Criteria
Inclusion
- Hospitalized with a diagnosis of preeclampsia.
- Gestational age ≥26 weeks.
- 18 years or older.
- Singleton and viable pregnancy.
- Willing to participate in the study voluntarily.
Exclusion
- Multiple pregnancy.
- Pregnancy achieved through assisted reproductive technologies.
- Hearing or vision impairment in the pregnant individual.
- Fetal distress requiring emergency intervention.
- HELLP Syndrome or Eclampsia.
- History of vertigo.
- Withdrawal Criteria:
- Cases where live birth does not occur.
- Participants who voluntarily withdraw from the study.
- Participants whose general health condition deteriorates during the intervention.
- Participants experiencing side effects from virtual reality headset use (e.g., dizziness, nausea, headache).
- Participants who do not practice progressive muscle relaxation at least once a week after the intervention.
Key Trial Info
Start Date :
September 8 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT06893510
Start Date
September 8 2025
End Date
September 1 2026
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ümraniye Training and Research Hospital
Istanbul, Turkey (Türkiye)